Related Experiment Videos

Goodpasture's Syndrome Following Alemtuzumab Therapy in Multiple Sclerosis

Emmanuelle Lapointe1, Bahar Moghaddam2, Krista Barclay3

  • 1Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|October 3, 2018
PubMed
Abstract

No abstract available in PubMed .

Keywords:
ImmunologyMultiple sclerosisPatient safety

Related Concept Videos